Atomo Diagnostics (ASX:AT1) Beginning Cash Position: A$3.22 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Atomo Diagnostics Beginning Cash Position?

Atomo Diagnostics ASX:AT1 +3.13% Beginning Cash Position is A$3.22 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Atomo Diagnostics's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$3.22 Mil.

Atomo Diagnostics's quarterly Beginning Cash Position declined from Dec. 2024 (A$3.69 Mil) to Jun. 2025 (A$2.90 Mil) but then increased from Jun. 2025 (A$2.90 Mil) to Dec. 2025 (A$3.22 Mil).

Atomo Diagnostics's annual Beginning Cash Position declined from Jun. 2023 (A$12.97 Mil) to Jun. 2024 (A$6.47 Mil) and declined from Jun. 2024 (A$6.47 Mil) to Jun. 2025 (A$3.69 Mil).

Atomo Diagnostics Beginning Cash Position Related Terms

Atomo Diagnostics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics Beginning Cash Position Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 27.11 17.95 12.97 6.47 3.69

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.47 6.51 3.69 2.90 3.22

Atomo Diagnostics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$3.22 Mil mean?
Atomo Diagnostics (ASX:AT1) has a Beginning Cash Position of A$3.22 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Atomo Diagnostics and its competitors.
Is Atomo Diagnostics' Beginning Cash Position too high?
Atomo Diagnostics' current Beginning Cash Position is A$3.22 Mil.
How does Atomo Diagnostics' Beginning Cash Position compare to ABT and SYK?
Atomo Diagnostics' Beginning Cash Position of A$3.22 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Atomo Diagnostics and its competitors. Atomo Diagnostics's current Beginning Cash Position is A$3.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 17.5% below its estimated fair value. The current Beginning Cash Position is A$3.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current Beginning Cash Position is A$3.22 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.